4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

There is increasing recognition of the crucial role of the right ventricle (RV) in determining
functional status and prognosis in multiple conditions. The normal RV is anatomically and …

Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …

The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

Sarcoidosis is a systemic granulomatous disease of unknown cause. Sarcoidosis involving
the heart, ie, cardiac sarcoidosis, affects the prognosis of patients significantly as it may lead …

Sarcoidosis is a complex disease with heterogeneous clinical presentations that can affect
virtually any organ. Although the lung is typically the most common organ involved …

As our understanding of the complications of coronavirus disease-2019 (COVID-19) evolve,
subclinical cardiac pathology such as myocarditis, pericarditis, and right ventricular …

Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …

Stress-induced myocardial perfusion defects have been firmly established as an important
diagnostic and prognostic technique for identifying flow-limiting epicardial coronary artery …

Background Sarcoidosis is a systemic disease characterized by significant clinical
heterogeneity. Although most frequently involving the lungs, sarcoidosis may affect any …